Editorial Comment from Dr Leow et al. to Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guerin failure in non-muscle invasive bladder cancer
- PMID: 36094833
- DOI: 10.1111/iju.15037
Editorial Comment from Dr Leow et al. to Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guerin failure in non-muscle invasive bladder cancer
Comment on
-
Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer.Int J Urol. 2022 Oct;29(10):1195-1203. doi: 10.1111/iju.14976. Epub 2022 Jul 20. Int J Urol. 2022. PMID: 35858755
References
REFERENCES
-
- Murakami Y, Matsumoto K, Miyake M, Amano N, Shimura S, Nishimura, et al. Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guerin failure in non-muscle-invasive bladder cancer. Int J Urol. 2022. https://doi.org/10.1111/iju.14976
-
- Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Dominguez Escrig JL, et al. European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur Urol. 2022;81(1):75-94.
-
- Nishimura N, Miyake M, Iida K, Miyamoto T, Tomida R, Numakura K, et al. Prognostication in Japanese patients with bacillus Calmette-Guerin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomy. Int J Urol. 2022;29(3):242-9.
-
- Martin-Doyle W, Leow JJ, Orsola A, Chang SL, Bellmunt J. Improving selection criteria for early cystectomy in high-grade T1 bladder cancer: a meta-analysis of 15,215 patients. J Clin Oncol. 2015;33(6):643-50.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical